wr 151327 has been researched along with Experimental Radiation Injuries in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Furukawa, S; Grdina, DJ; Koike, S; Matsushita, S | 1 |
| Garnes, BA; Grdina, DJ; Nagy, B | 1 |
| Elliott, TB; Harding, RA; Henderson, PL; Landauer, MR; Ledney, GD; Tom, SP; Vigneulle, RM | 1 |
3 other study(ies) available for wr 151327 and Experimental Radiation Injuries
| Article | Year |
|---|---|
Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation.
Topics: Animals; Epidermis; Female; Gamma Rays; Hindlimb; Mice; Mice, Inbred C3H; Muscle Contraction; Muscle, Skeletal; Muscular Atrophy; Organothiophosphorus Compounds; Radiation Injuries, Experimental; Radiation-Protective Agents; Skin | 1994 |
Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons.
Topics: Amifostine; Animals; Female; Gamma Rays; Male; Mice; Mice, Inbred Strains; Mutagenesis; Neoplasms, Radiation-Induced; Neutrons; Organothiophosphorus Compounds; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Sex Factors; Survival Rate; Time Factors | 1992 |
Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Cord Factors; Female; Gamma Rays; Gram-Negative Bacterial Infections; Liver; Mice; Mice, Inbred Strains; Neutrons; Ofloxacin; Organothiophosphorus Compounds; Radiation Injuries, Experimental; Radiation Tolerance; Radiation-Protective Agents; Survival Rate | 1994 |